FundedIQ
Biotechnology

SpineThera: Funding, Investors & Team (Sep 2026)

SpineThera develops novel, sustained-release, injectable drugs to treat pain; offering patients and physicians alternatives that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs. It was founded in 2012 and is headquartered in Plymouth, Minnesota.

www.spinethera.com LinkedIn Plymouth, United States 1-10 employees
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Total raised
$5.0M
Rounds
1
Latest
Grant
Apr 2022

SpineThera has raised $5.0M across 1 funding round on record, the most recent a Grant of $5.0M announced in Apr 2022.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

SpineThera Company Profile and Key Stats

Total funding raised
$5.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Grant
$5.0M in Apr 2022
Employees
1-10
reported band
Headquarters
Plymouth, United States

Latest funding round on record: Apr 2022.

SpineThera Funding Rounds

Date
Round
Amount
Grant
$5.0M

SpineThera Founders and Leadership Team

Name
Role
Contact
Jeff Missling
CEO

No contact details are on record for this team yet.

SpineThera Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M
1,065

SpineThera's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like SpineThera in Biotechnology and Plymouth

Companies Similar to SpineThera

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

SpineThera Funding FAQs

What does SpineThera do?

SpineThera develops novel, sustained-release, injectable drugs to treat pain; offering patients and physicians alternatives that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs. It was founded in 2012 and is headquartered in Plymouth, Minnesota.

How much funding has SpineThera raised?

SpineThera has raised $5.0M across 1 round on record. The most recent is a Grant of $5.0M announced in Apr 2022.

When did SpineThera last raise funding?

SpineThera's most recent funding round on record is a Grant of $5.0M, announced in Apr 2022.

Who is the CEO of SpineThera?

Jeff Missling is listed as CEO at SpineThera.

Where is SpineThera headquartered?

SpineThera is based in Plymouth, Minnesota, United States.

How many employees does SpineThera have?

SpineThera is in the 1-10 employee band.

How does SpineThera's funding compare to other Biotechnology startups?

SpineThera's latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's SpineThera Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SpineThera is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.